Liraglutide for Weight Loss: What You Need to Know in 2025
Liraglutide is a GLP-1 receptor agonist initially developed for diabetes, but now widely used for weight management under the brand name Saxenda. As of 2025, it remains an effective tool for patients looking for non-surgical obesity solutions.
❓ What makes Liraglutide effective?
It slows gastric emptying and increases feelings of fullness, helping patients reduce calorie intake. When combined with lifestyle changes, it can lead to gradual, sustained weight loss.
📏 Typical Dosage
Starting at 0.6 mg daily, the dose is titrated up to 3.0 mg over several weeks. The daily injection is usually well-tolerated with proper guidance.
⚠️ Common Side Effects
- Nausea or constipation
- Fatigue or dizziness
- Rarely, pancreatitis symptoms
Liraglutide is often compared with more recent agents like Semaglutide or Tirzepatide, which may offer greater weight loss but are more expensive or less accessible.
For a complete overview of GLP-1 therapies, visit our expert review: Top GLP-1 Drugs for Diabetes and Obesity in 2025.